acamprosate calcium (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the acamprosate calcium drug offered from Cadila Healthcare Limited. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
| NON-PROPRIETARY NAME: | acamprosate calcium |
| SUBSTANCE NAME: | ACAMPROSATE CALCIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-06-01 |
| END MARKETING DATE: | 0000-00-00 |
acamprosate calcium HUMAN PRESCRIPTION DRUG Details:
| Item Description | acamprosate calcium from Cadila Healthcare Limited |
| LABELER NAME: | Cadila Healthcare Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 333(mg/1) |
| START MARKETING DATE: | 2017-06-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70771-1057_7e5f02ce-f964-4059-ae7e-a862e17bfe9e |
| PRODUCT NDC: | 70771-1057 |
| APPLICATION NUMBER: | ANDA205995 |
Other ACAMPROSATE CALCIUM Pharmaceutical Manufacturers / Labelers:
